Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 24 studies with search of: | "Bismuth" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Comparison of 7-Day and 14-Day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
|
||||
2 | Recruiting |
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
|
||||
3 | Completed |
Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection
|
||||
4 | Not yet recruiting |
Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration
|
||||
5 | Completed |
Treatment of Microscopic Colitis
|
||||
6 | Active, not recruiting |
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
|
||||
7 | Active, not recruiting |
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
|
||||
8 | Active, not recruiting |
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
|
||||
9 | Recruiting |
Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures
|
||||
10 | Recruiting |
Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy
|
||||
11 | Completed |
A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3
|
||||
12 | Active, not recruiting |
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
|
||||
13 | Completed |
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
|
||||
14 | Completed |
A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.
|
||||
15 | Active, not recruiting |
Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
|
||||
16 | Completed |
Gastric pH in Critically Ill Patients
|
||||
17 | Withdrawn |
Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer
|
||||
18 | Completed |
Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-Induced Gastric Ulcer
|
||||
19 | Completed |
The Effect of Stomach Acid on Foscarnet
|
||||
20 | Completed |
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
|
Previous Page | Studies Shown (1-20) | Next Page (21-24) |